Corrigendum: Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial

Frontiers in Endocrinology

Qian Zhao¹  Kan Wang¹  Yanling Liu²  Zaiyan Gu²  Li Xi³  Hongxiao Zhang⁴  Feihong Luo⁵  Hong Zhu⁶  Ruoqian Cheng⁷  Zhihong Jiang⁸  Yanjie Liu⁹  Naijun Wan^1,10  Chengming Yan^1,11  Jianying Yin^1,12  Lirong Ying^1,13  Feng Huang^1,14  Qingjin Yin^1,15  Kan Ye^1,16  Pei Hu^1,16  Yaqin Zhang^1,17  Jin Ye^1,18  Yu Liu^1,19  Chengjun Sun^2,20  Haiyan Wei^2,21  Biao Lu^2,22  Xu Hu^2,23  Zheng Liu^2,24 

[1] PD) Investigation for Innovative Drugs, Chinese Academy of Medical Sciences &Peking Union Medical College, Beijing, China;0Department of Pediatrics, Hebei General Hospital, Shijiazhuang, China;0Department of Pediatrics, Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China;1Department of Pediatrics, Cixi People’s Hospital, Cixi, China;1Department of Pediatrics, Jiaxing First Hospital, Jiaxing, China;2Department of Pediatrics, Affiliated Hospital of Nantong University, Nantong, China;2Department of Pediatrics, Tai’an Maternal and Child Health Care Hospital, Tai’an, China;3Department of Pediatrics, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China;4Department of Pediatrics, Second Hospital of Lanzhou University, Lanzhou, China;5Department of Pediatrics, The First People’s Hospital of Changzhou, Changzhou, China;6Department of Pediatrics, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China;7Department of Pediatrics, Inner Mongolia People’s Hospital, Hohhot, China;8Department of Pediatrics, Jishuitan Hospital, Beijing, China;9Department of Pediatrics, Anhui Province Maternity and Child Health Hospital, Anhui Medical University Maternal and Child Health Clinic College, Hefei, China;;Clinical Pharmacology Research Center, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, National Medical Products Administration (NMPA) Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical Pharmacokinetics and Pharmacodynamics (PK &Department of Child Health, Maternal and Child Health Care Hospital of Hainan Province, Haikou, China;Department of Child Health, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China;Department of Endocrine and Genetic Metabolism, Maternal and Child Health-Care Hospital in Guiyang, Guiyang, China;Department of Pediatric Endocrinology and Inherited Metabolic Diseases, Children’s Hospital of Fudan University, Shanghai, China;Department of Pediatric Endocrinology and Inherited Metabolic Diseases, Henan Provincial Hospital, Affiliated to Zhengzhou University, Zhengzhou, China;Department of Pediatrics, General Hospital of Ningxia Medical University, Yinchuan, China;Department of Pediatrics, Lu’an People’s Hospital, Lu’an, China;Department of Pediatrics, The Second Affiliated Hospital of Nanchang University, Nanchang, China;

关键词: growth hormone deficiency;    PEGylated recombinant human growth hormone;    PEG-rhGH;    IGF-2;    children;   

DOI  :  10.3389/fendo.2021.830469

来源: DOAJ

【 授权许可】

Unknown